Abstract
In this issue of Blood, Zhang et al identify and characterize an imatinib-resistant mutation (PDGFRB C843G) in a B-progenitor acute lymphoblastic leukemia (B-ALL) patient harboring a novel AGGF1-PDGFRB fusion.1.
Cite
CITATION STYLE
APA
Roberts, K. G. (2018, May 17). TKI resistance in Ph-like ALL. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2018-03-833665
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free